myCareGPS

myCareGPS is transitional and chronic care management software that gets measurable results by simplifying care coordination, generating revenue and managing costs. myCareGPS is a centralized patient-focused platform that navigates the patient along the care continuum and provides real-time communication between doctors, caregivers, patients and families in real-time. We deliver better outcomes for the patient, for the organization, for the bottom line and it's inter-operable and easy to integrate.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

HEALTH TECHNOLOGY

TRIHEALTH INVESTS IN AI WORKFORCE TO DRIVE ENTERPRISE-WIDE INNOVATION

TriHealth | May 06, 2021

news image

TriHealth, the Cincinnati region's nationally recognized integrated health system, announced today their partnership with Olive, the company delivering innovation to healthcare through artificial intelligence (AI), to implement an AlphaSite — an on-site AI command center. The addition of Olive wil...

Read More

HEALTH TECHNOLOGY

WEAVE LAUNCHES MULTI-LOCATION PATIENT ENGAGEMENT PLATFORM

Weave | February 09, 2021

news image

Weave, a well-known and a fastest growing tech company announced a sophisticated patient communication and engagement platform, which is called Weave Unify. This is a multi-location service and created specifically for the same business. Weave, a complete business toolbox for service-based busines...

Read More

HEALTH TECHNOLOGY

ALKEM LABORATORIES LTD. TO LAUNCH STATE OF THE ART TECHNOLOGY FOR DIABETIC FOOT ULCER MANAGEMENT

Alkem Laboratories Ltd. | January 13, 2022

news image

Alkem Laboratories Ltd. (Alkem) hereby announces to launch a unique patented technology for the treatment of Diabetic Foot Ulcer (DFU) in India. The solution would be based on disruptive 4D Bioprinting technology, which would be used to treat deep, non-healing chronic wounds and is expected to be launched in the Indian market in the latter half of 2022 post regulatory approval. This advanced technology for DFU management has a high scope of preventing amputations in diabetic patients. This te...

Read More

CMS ANNOUNCED AN INCREASE IN INPATIENT RATES, NEW HOSPITAL PAYMENT CATEGORY FOR CAR T

CMS | May 12, 2020

news image

CMS announced the payment adjustment, which could also include potential penalties for excess readmissions. The proposed changes also include creating a new hospital payment category for chimeric antigen receptor (CAR) T-cell therapy. <...

Read More
news image

HEALTH TECHNOLOGY

TRIHEALTH INVESTS IN AI WORKFORCE TO DRIVE ENTERPRISE-WIDE INNOVATION

TriHealth | May 06, 2021

TriHealth, the Cincinnati region's nationally recognized integrated health system, announced today their partnership with Olive, the company delivering innovation to healthcare through artificial intelligence (AI), to implement an AlphaSite — an on-site AI command center. The addition of Olive wil...

Read More
news image

HEALTH TECHNOLOGY

WEAVE LAUNCHES MULTI-LOCATION PATIENT ENGAGEMENT PLATFORM

Weave | February 09, 2021

Weave, a well-known and a fastest growing tech company announced a sophisticated patient communication and engagement platform, which is called Weave Unify. This is a multi-location service and created specifically for the same business. Weave, a complete business toolbox for service-based busines...

Read More
news image

HEALTH TECHNOLOGY

ALKEM LABORATORIES LTD. TO LAUNCH STATE OF THE ART TECHNOLOGY FOR DIABETIC FOOT ULCER MANAGEMENT

Alkem Laboratories Ltd. | January 13, 2022

Alkem Laboratories Ltd. (Alkem) hereby announces to launch a unique patented technology for the treatment of Diabetic Foot Ulcer (DFU) in India. The solution would be based on disruptive 4D Bioprinting technology, which would be used to treat deep, non-healing chronic wounds and is expected to be launched in the Indian market in the latter half of 2022 post regulatory approval. This advanced technology for DFU management has a high scope of preventing amputations in diabetic patients. This te...

Read More
news image

CMS ANNOUNCED AN INCREASE IN INPATIENT RATES, NEW HOSPITAL PAYMENT CATEGORY FOR CAR T

CMS | May 12, 2020

CMS announced the payment adjustment, which could also include potential penalties for excess readmissions. The proposed changes also include creating a new hospital payment category for chimeric antigen receptor (CAR) T-cell therapy. <...

Read More